FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to an non-aqueous pharmaceutical composition containing dehydrated active polypeptide containing 10-100 amino acids, and at least one semipolar proton organic solvent, with polypeptide dehydrated at pre-set pH differing by at least 1 pH unit from pi polypeptide in the aqueous solution and to a method for preparing the composition.
EFFECT: group of inventions provides improved stability of the non-aqueous composition of therapeutic peptide.
39 cl, 7 ex, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ACYLATED INSULIN ANALOGUES STABILISED WITH RESPECT TO PROTEASES | 2009 |
|
RU2571857C2 |
| CHROMATOGRAPHIC METHODS AND COMPOUNDS PURIFIED USING SAID METHODS | 2010 |
|
RU2508294C2 |
| PREPARATION CONTAINING INSULIN, NICOTINAMIDE AND AMINO ACID | 2010 |
|
RU2533217C2 |
| NOVEL INSULIN DERIVATIVES AND USE THEREOF | 2015 |
|
RU2684456C2 |
| METHOD FOR PREPARATION OF INSULIN COMPOUNDS | 2002 |
|
RU2376379C2 |
| PROTEASE-RESISTANT INSULIN ANALOGUES | 2007 |
|
RU2524150C2 |
| INSULIN ANALOGUES | 2017 |
|
RU2769476C2 |
| CONJUGATE OF LONG-ACTING PHYSIOLOGICALLY ACTIVE SUBSTANCE AND ITS USE | 2018 |
|
RU2773823C2 |
| INSULIN DERIVATIVES CONTAINING ADDITIONAL DISULFIDE BONDS | 2011 |
|
RU2598273C2 |
| INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
